Cowen and Company’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Cowen and Company’s Portfolio MSACW Stock Details MSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-52,887	Closed	-$4.76K	–	789
2022 Q4	$4.76K	Hold	52,887	–	–	﹤0.01%	496
2022 Q3	$9K	Buy	+52,887	New	+$10.1K	﹤0.01%	441

Cowen and Company's MSACW Position: Q1 2023 in Review

Cowen and Company sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 52,887 shares — an estimated $4.76K sold.

Cowen and Company first reported a position in MSACW in Q3 2022 and held it in 2 quarters. The position peaked at $9K in Q3 2022. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

Cowen and Company reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Cowen and Company sold 52,887 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $4.76K.
Cowen and Company first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q3 2022 and held it in 2 quarters.
Cowen and Company's Medicus Sciences Acquisition Corp. Warrant position peaked at $9K in Q3 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.